Related Experiment Videos
Treatment of malignant melanoma with methyl CCNU
Clinical Pharmacology and Therapeutics
|June 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2010
Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.
Biochemical pharmacology·2010
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2003
Complementary, alternative, integrative, or unconventional medicine?
The oncologist·2001
Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.
Clinical pharmacology and therapeutics·2026
Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.
Clinical pharmacology and therapeutics·2026
The Governance Gap: Democratizing Drug Development Through Decision Architecture.
Clinical pharmacology and therapeutics·2026
Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real-World Data: The INVESTED-Medicare Linkage Study.
Clinical pharmacology and therapeutics·2026
Analysis of Suffix Use for Biosimilar Product Identification in Postmarketing Adverse Event Reporting.
Clinical pharmacology and therapeutics·2026
Special Populations in Pivotal Clinical Trials: Eligibility and Supporting Evidence for Exclusion in EMA-Authorised Medicines.
Clinical pharmacology and therapeutics·2026
AMETHYST: a Retrospective Cohort Study of Treatment Patterns and Outcomes in Patients With Glucocorticoid-refractory Macrophage Activation Syndrome Complicating Still's Disease.
Arthritis & rheumatology (Hoboken, N.J.)·2026